ZHANG Zhu, FAN Xiucai, LIU Pingang, TAO Liangliang. Value of thromboelastography in analyzing blood hypercoagulability and ischemic events after percutaneous coronary intervention in coronary heart disease patients with anti-platelet drug therapy[J]. Journal of Clinical Medicine in Practice, 2021, 25(21): 43-46. DOI: 10.7619/jcmp.20213934
Citation: ZHANG Zhu, FAN Xiucai, LIU Pingang, TAO Liangliang. Value of thromboelastography in analyzing blood hypercoagulability and ischemic events after percutaneous coronary intervention in coronary heart disease patients with anti-platelet drug therapy[J]. Journal of Clinical Medicine in Practice, 2021, 25(21): 43-46. DOI: 10.7619/jcmp.20213934

Value of thromboelastography in analyzing blood hypercoagulability and ischemic events after percutaneous coronary intervention in coronary heart disease patients with anti-platelet drug therapy

More Information
  • Received Date: October 04, 2021
  • Available Online: November 22, 2021
  • Published Date: November 14, 2021
  •   Objective  To investigate the value of thromboelastography (TEG) in analyzing blood hypercoagulability and ischemic events after percutaneous coronary intervention (PCI) in coronary heart disease (CHD) patients with anti-platelet drug therapy.
      Methods  A total of 118 CHD patients with PCI were selected as objects, and they were divided into TEG group and routine group according to whether TEG was taken after operation. The result of TEG and coagulation indexes were compared between the two groups, and the incidence of ischemic events and bleeding events at 6 months after surgery was observed.
      Results  There were no significant differences in clinical materials between the TEG group and routine group (P>0.05). The coagulation reaction time (R), kinetics of clot development (K), inhibition rates of arachidonic acid (AA) and adenosine diphosphate (ADP) in the TEG group were significantly higher than those in the routine group, while the speed of blood clot formation (α angle) and maximum amplitude of clot (MA) were significantly lower than those in the routine group (P < 0.05). Prothrombin time (PT) and fibrinogen (FIB) in the TEG group were significantly lower than those in the routine group, while activated partial thromboplastin time (APTT) and thrombin time (TT) were significantly higher than those in routine group (P < 0.05). There were significant differences in the incidence rates of ischemic events and bleeding events at 6 months after operation between the two groups (P < 0.05).
      Conclusion  TEG-guided anti-platelet drug therapy is beneficial to the rapid improvement of blood hypercoagulability after PCI in CHD patients, which can reduce the incidence rates of ischemia and bleeding events after PCI in CHD patients.
  • [1]
    DRAGANO N, SIEGRIST J, NYBERG S T, et al. Effort-reward imbalance at work and incident coronary heart disease: a multicohort study of 90, 164 individuals[J]. Epidemiology, 2017, 28(4): 619-626. doi: 10.1097/EDE.0000000000000666
    [2]
    YUBERO-SERRANO E M, ALCALÁ-DIAZ J F, GUTIERREZ-MARISCAL F M, et al. Association between cholesterol efflux capacity and peripheral artery disease in coronary heart disease patients with and without type 2 diabetes: from the CORDIOPREV study[J]. Cardiovasc Diabetol, 2021, 20(1): 72. doi: 10.1186/s12933-021-01260-3
    [3]
    BHATT D L. Percutaneous coronary intervention in 2018[J]. JAMA, 2018, 319(20): 2127-2128. doi: 10.1001/jama.2018.5281
    [4]
    VERHEUGT F W A. Antithrombotic therapy to reduce ischemic events in acute coronary syndromes patients undergoing percutaneous coronary intervention[J]. Interv Cardiol Clin, 2017, 6(1): 131-140. http://www.onacademic.com/detail/journal_1000039745119310_22f9.html
    [5]
    ALI J T, DALEY M J, VADIEI N, et al. Thromboelastogram does not detect pre-injury anticoagulation in acute trauma patients[J]. Am J Emerg Med, 2017, 35(4): 632-636. doi: 10.1016/j.ajem.2016.12.061
    [6]
    伍小青, 叶汉深, 陈漫标. 血栓弹力图指导体外循环心血管术后输血的分析[J]. 中国输血杂志, 2019, 32(8): 789-791. https://www.cnki.com.cn/Article/CJFDTOTAL-BLOO201908020.htm
    [7]
    钟涛, 许伟, 胡海亮, 等. 应用TEG监测冠心病患者的凝血状态及评价抗血小板聚集效果的临床研究[J]. 中国实验血液学杂志, 2018, 26(5): 1484-1491. https://www.cnki.com.cn/Article/CJFDTOTAL-XYSY201805041.htm
    [8]
    中华医学会心血管病学分会介入心脏病学组中国医师协会心血管内科医师分会血栓防治专业委员会中华心血管病杂志编辑委员会. 中国经皮冠状动脉介入治疗指南(2016)[J]. 中华心血管病杂志, 2016, 44(5): 382-400. doi: 10.3760/cma.j.issn.0253-3758.2016.05.006
    [9]
    张瑶, 王莹, 于欢, 等. 血栓弹力图指导冠状动脉介入治疗患者使用抗血小板药物的临床研究[J]. 中国药学杂志, 2014, 49(10): 877-880. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYX201410019.htm
    [10]
    PAGLIARO B R, CANNATA F, STEFANINI G G, et al. Myocardial ischemia and coronary disease in heart failure[J]. Heart Fail Rev, 2020, 25(1): 53-65. doi: 10.1007/s10741-019-09831-z
    [11]
    BAI M F, WANG X. Risk factors associated with coronary heart disease in women: a systematic review[J]. Herz, 2020, 45(Suppl 1): 52-57. doi: 10.1007/s00059-019-4835-2
    [12]
    FIGULLA H R, LAUTEN A, MAIER L S, et al. Percutaneous coronary intervention in stable coronary heart disease is less more[J]. Deutsches Aerzteblatt Online, 2020, 117(9): 137-144. http://med.wanfangdata.com.cn/Paper/Detail/PeriodicalPaper_PM32234189
    [13]
    SIM D S, JEONG M H, JEONG M H, et al. Clopidogrel versus aspirin after dual antiplatelet therapy in acute myocardial infarction patients undergoing drug-eluting stenting[J]. Korean Circ J, 2020, 50(2): 120-129. doi: 10.4070/kcj.2019.0166
    [14]
    OO J, ALLEN M, LOVEDAY B P T, et al. Coagulation in liver surgery: an observational haemostatic profile and thromboelastography study[J]. ANZ J Surg, 2020, 90(6): 1112-1118. doi: 10.1111/ans.15912
    [15]
    ABU ASSAB T, RAVEH-BRAWER D, ABRAMOWITZ J, et al. The predictive value of thromboelastogram in the evaluation of patients with suspected acute venous thromboembolism[J]. Acta Haematol, 2020, 143(3): 272-278. doi: 10.1159/000502348
    [16]
    HOTA S, NG M, HILLIARD D, et al. Thromboelastogram-guided resuscitation for patients with traumatic brain injury on novel anticoagulants[J]. Am Surg, 2019, 85(8): 861-864. doi: 10.1177/000313481908500839
    [17]
    IBA T, LEVY J H. Inflammation and thrombosis: roles of neutrophils, platelets and endothelial cells and their interactions in Thrombus formation during Sepsis[J]. J Thromb Haemost, 2018, 16(2): 231-241. doi: 10.1111/jth.13911
    [18]
    TURGEON R D, YOUNGSON E, GRAHAM M M. Risk of pneumonia with ticagrelor versus clopidogrel: a population-based cohort study[J]. J Gen Intern Med, 2021, 36(7): 2158-2160. doi: 10.1007/s11606-020-06131-3
    [19]
    ZHANG J, WANG Z, SANG W, et al. Omission of aspirin in patients taking oral anticoagulation after percutaneous coronary intervention: a systematic review and meta-analysis[J]. Coron Artery Dis, 2019, 30(2): 109-115. doi: 10.1097/MCA.0000000000000698
    [20]
    ZHAO S W, WANG Y P, XU L D, et al. The application of thromboelastogram in detection of indexes of antiplatelet therapy for coronary heart disease[J]. J Thorac Dis, 2016, 8(12): 3515-3520. doi: 10.21037/jtd.2016.12.77
  • Cited by

    Periodical cited type(11)

    1. 吕皓,吕坚. 冠心病患者PCI术后凝血纤溶指标变化及MACE影响因素分析. 心电与循环. 2025(01): 41-45 .
    2. 苏维泉,姚卫华,李恩会. 冠状动脉闭塞患者行冠状动脉搭桥术围术期血栓弹力图及凝血功能变化分析. 黑龙江医药科学. 2025(03): 84-85+89 .
    3. 夏文君,卢嘉成. 针刺联合西药治疗心血瘀阻型胸痹的疗效观察及对血栓弹力图结果的影响. 上海针灸杂志. 2024(03): 278-282 .
    4. 刘华,林芬. 血流储备分数与冠状动脉造影在冠心病经皮冠状动脉介入术中的应用价值. 医疗装备. 2024(06): 75-77 .
    5. 胡国安. 血栓弹力图在凝血功能异常诊断中的应用及与凝血功能的关系. 人人健康. 2023(01): 108-110 .
    6. 李荣芳,甘福生,陈智华,罗海良,刘小梅. sdLDL、LDL及TEG在高脂血症患者颈动脉粥样硬化诊断中的应用. 中国医学创新. 2023(16): 18-22 .
    7. 张楠楠,韩晓燕,孙玉洁,李小杰,李佳慧,刘业松. 血栓弹力图评估阿司匹林及氯吡格雷对冠心病PCI术后患者的应用效果. 中国煤炭工业医学杂志. 2023(06): 616-620 .
    8. 张娟,李秀琴,张呈球,王文萍,王子峰. 血栓弹力图对费城染色体阴性骨髓增殖性肿瘤患者凝血状态的评估价值. 癌症进展. 2023(24): 2753-2756 .
    9. 朱小倩. 血栓弹力图(TEG)在冠心病凝血监测中的临床应用分析. 中西医结合心血管病电子杂志. 2023(32): 27-29 .
    10. 邵超,高文灿,张军,沈滨,许建伟,殷凯. 普通外科术后下肢深静脉血栓形成预测模型的建立. 实用临床医药杂志. 2022(22): 12-15+19 . 本站查看
    11. 唐敏鑫,全浪,胡锐. 骨科大手术围术期血栓弹力图的应用研究进展. 系统医学. 2022(23): 195-198 .

    Other cited types(3)

Catalog

    Article views (203) PDF downloads (8) Cited by(14)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return